Digital Towards one, cohesive AI workflow: In conversation with Ilya... In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Ilya Burkov, global head of healthcare & life sciences at Nebius, about AI.
Sales & Marketing Collaborating on a connected platform journey, with Alexande... pharmaphorum speaks with Bayer's Alexander Alex and Veeva's Florian Schnappauf about Bayer's recent migration to the connected Vault CRM platform.
Oncology ESMO25: Patient-centric oncological futures with Boehringer ... On new oncology data from Boehringer Ingelheim, with Lykke Hinsch Gylvin, chief medical officer, and Itziar Canamasas, head of oncology, at ESMO 2025.
Market Access Smoothing a contract pathway through uncertainty: In convers... Today's podcast with Entity Risk's Neal Masia includes insights on the 340B Program, PBMs, and risk-based contracts.
Digital FH25: On the future of health, with Frontiers Health Chairma... In the final episode of our special Frontiers Health limited series, conference Chairman Roberto Ascione discusses his favourite moments and insights.
R&D Allosteric small molecule therapies in PD, with Gene Mack pharmaphorum looks back to a conversation with Gain Therapeutics' CEO Gene Mack earlier in the year, on research in the Parkinson's disease space.
News Agios mulls early FDA filing for sickle cell therapy Agios is planning to file its sickle cell disease candidate mitapivat with the FDA under the accelerated pathway within the next few months.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.